pyrazines has been researched along with azd2014 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, KA; Carnevalli, LS; Cheung, J; Clevenger, TN; Collins, GP; Cunningham, D; Dougherty, BA; Flinn, I; Fox, CP; Frigault, MM; Goy, A; Gribben, J; Hamdy, A; Harrington, EA; Izumi, R; MacDonald, A; Nowakowski, GS; Nuttall, B; Pease, JE; Raymond, A; Roschewski, M; Schalkwijk, S; Stetson, D; Tao, L; Vallurupalli, A; Vose, JM; Willis, B; Yang, B | 1 |
1 trial(s) available for pyrazines and azd2014
| Article | Year |
|---|---|
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.
Topics: B-Lymphocytes; Benzamides; Humans; Morpholines; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Pyrazines; Pyrimidines | 2021 |